Suven Pharmaceuticals Ltd. | Large-cap | Healthcare
₹1,002.00
2.57%
| Suven Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 12.0B
Gross Profit 8.9B 74.51%
Operating Income 3.0B 24.86%
Net Income 2.6B 22.11%
EPS (Diluted) ₹10.45

Balance Sheet Metrics

Total Assets 30.3B
Total Liabilities 11.9B
Shareholders Equity 18.4B
Debt to Equity 0.65

Cash Flow Metrics

Operating Cash Flow 2.9B
Free Cash Flow 1.3B

Revenue & Profitability Trend

Suven Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 12.0B 10.4B 13.3B 13.1B 10.0B
Cost of Goods Sold 3.1B 4.5B 5.9B 5.7B 4.4B
Gross Profit 8.9B 5.9B 7.4B 7.3B 5.6B
Operating Expenses 2.7B 566.6M 701.8M 649.0M 544.0M
Operating Income 3.0B 3.5B 5.3B 5.4B 4.1B
Pre-tax Income 3.4B 4.1B 5.6B 6.7B 4.7B
Income Tax 791.5M 1.1B 1.5B 2.1B 1.1B
Net Income 2.6B 3.0B 4.1B 4.5B 3.6B
EPS (Diluted) ₹10.45 ₹11.80 ₹16.16 ₹17.83 ₹14.23

Income Statement Trend

Suven Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 8.9B 12.6B 10.1B 11.3B 5.6B
Non-Current Assets 21.4B 9.9B 9.5B 7.0B 9.1B
Total Assets 30.3B 22.5B 19.7B 18.3B 14.7B
Liabilities
Current Liabilities 3.7B 1.1B 1.6B 2.1B 2.2B
Non-Current Liabilities 8.3B 965.3M 717.9M 921.1M 739.2M
Total Liabilities 11.9B 2.0B 2.3B 3.0B 2.9B
Equity
Total Shareholders Equity 18.4B 20.5B 17.4B 15.3B 11.8B

Balance Sheet Composition

Suven Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 3.4B 4.1B 5.6B 6.7B 4.7B
Operating Cash Flow 2.9B 4.9B 6.1B 4.5B 4.6B
Investing Activities
Capital Expenditures -1.6B -517.9M -2.9B -751.9M -1.1B
Investing Cash Flow -2.6B -3.6B -2.0B 1.1B -3.1B
Financing Activities
Dividends Paid - - -2.0B -1.0B -254.6M
Financing Cash Flow 227.9M -270.4M -2.1B -1.4B -129.0M
Free Cash Flow 1.3B 3.1B 1.7B 2.5B 2.7B

Cash Flow Trend

Suven Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 99.01
Forward P/E 51.38
Price to Book 13.88
Price to Sales 39.38
PEG Ratio -9.13

Profitability Ratios

Profit Margin 26.63%
Operating Margin 31.70%
Return on Equity 14.38%
Return on Assets 8.73%

Financial Health

Current Ratio 2.43
Debt to Equity 1.95
Beta 1.13

Per Share Data

EPS (TTM) ₹10.90
Book Value per Share ₹77.73
Revenue per Share ₹41.18

Financial data is updated regularly. All figures are in the company's reporting currency.